Annual report pursuant to section 13 and 15(d)

CONSOLIDATED STATEMENTS OF OPERATIONS

v2.4.0.8
CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)
In Thousands, except Share data, unless otherwise specified
12 Months Ended 79 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2013
COSTS AND EXPENSES:      
Research and development $ 4,650 $ 2,584 $ 9,185
General and administrative 6,238 4,078 14,572
Total operating expenses 10,888 6,662 23,757
Operating Loss (10,888) (6,662) (23,757)
Gain on extinguishment of debt 0 0 8
Other income 0 2 2
Change in fair value of warrant liability 0 (1,177) (1,177)
Interest and other financing costs, net 4 (1,613) (1,804)
NET LOSS $ (10,884) $ (9,450) $ (26,728)
Net loss per common share, basic and diluted (in dollars per share) $ (3.37) $ (5.58)  
Weighted average common shares outstanding, basic and diluted (in shares) 3,231,311 1,693,416